There were 1,401 press releases posted in the last 24 hours and 403,611 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.